Kamil Ali Jackson Rigel Pharmaceuticals Inc (RIGL) insider trading activity

Kamil Ali Jackson is of RIGEL PHARMACEUTICALS INC. Currently has a direct ownership of 68,750 shares of RIGL, which is worth approximately $915,750. The most recent transaction as insider was on May 25, 2024, when has been sold 25,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 68.8K

0% 3M change

57.14% 12M change

Total Value Held $915,750

Kamil Ali-Jackson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 25 2024	BUY Grant, award, or other acquisition	-	25,000 Added 26.67%	68,750 Common Stock
May 26 2023	BUY Grant, award, or other acquisition	-	25,000 Added 36.36%	43,750 Common Stock
May 20 2022	BUY Grant, award, or other acquisition	-	18,750 Added 50.0%	18,750 Common Stock

Also insider at

ACRS

Aclaris Therapeutics, Inc. Healthcare

Chief Legal Officer

PDSB

PDS Biotechnology Corp Healthcare